LC/MS, LC/MS/MS, LC/QQQ
IndustriesPharma & Biopharma
ManufacturerAgilent Technologies
Significance of the Topic
The accurate measurement of 25-hydroxyvitamin D2 and D3 metabolites and their epimeric forms is critical for assessing vitamin D status in clinical and research settings. Conventional chemiluminescent immunoassays can suffer from cross-reactivity and overestimation due to epimer interference. A robust LC-MS/MS approach that achieves chromatographic baseline separation of epimers enhances specificity, sensitivity, and reliability of vitamin D metabolite quantitation.
Study Objectives and Overview
This study aimed to develop and validate a sensitive, high-throughput LC-MS/MS method using the Agilent Ultivo triple quadrupole system to simultaneously separate and quantify 25(OH)D2, 25(OH)D3 and their respective C3-epimers. The poster detailed method optimization, performance metrics, and comparison to reference standards.
Instrumentation Used
- Agilent 1260 Infinity II Binary Pump and Multisampler with inline filter
- Agilent 1260 Infinity II Column Compartment
- Agilent Ultivo LC/TQ with Jet Stream (AJS) source
- Agilent Poroshell 120 PFP column (3.0×100 mm, 2.7 µm)
- MassHunter Acquisition and Quantitative Analysis software
Experimental Methodology
Sample Preparation:
- 200 µL human serum protein-precipitated with organic solvent
- Vortex, incubation, centrifugation, supernatant injection
Chromatography:
- Mobile phases: water and methanol, both with 0.1% formic acid
- 10-minute gradient from 65% to 95% B and re-equilibration
Mass Spectrometry:
- Positive MRM mode with optimized transitions for analytes and deuterated internal standards
- MRM dwell time 100 ms, gas and voltage settings tuned for stability
Calibration & Validation:
- Nine calibrators spanning 0.4–200 ng/mL with ISTD at 8 ng/mL
- QC levels at 4, 10, 20 ng/mL to evaluate recovery, precision, matrix effects
Key Results and Discussion
Linearity & Sensitivity:
- Linear response for all targets from LOQ to 200 ng/mL, R² > 0.999
- LOQ of 1 ng/mL for 25(OH)D2, 0.4 ng/mL for 25(OH)D3
Precision & Accuracy:
- Retention time RSD <0.3%, response precision <5%
- Accuracy within 95–115% across range
Recovery & Matrix Effects:
- Recoveries 91–111%, intra-batch RSD ≤2%
- Matrix suppression >87%, indicating minimal interference
Robustness:
- 500-injection run over 3.5 days without retuning
- Concentration and RT RSD ≤5% and ≤0.2%, respectively
Reference Standard Testing:
- Chromsystems standards confirmed baseline separation of D2/D3 epimers
- Recoveries 97–109%, RSD ≤4%
Benefits and Practical Applications
The method offers improved specificity over immunoassays by resolving isobaric epimers, reducing quantitation bias. High throughput and robustness support routine clinical diagnostics, nutritional studies, and large-scale epidemiological surveys. The approach can be implemented in labs equipped with triple quadrupole LC-MS/MS systems.
Future Trends and Possibilities
Advancements may include microflow LC to reduce solvent use, multiplexing additional vitamin D metabolites, and integration with automated sample prep. Expanding to non-serum matrices (e.g., plasma, tissue homogenates) and coupling with high-resolution MS could further enhance metabolite profiling.
Conclusion
A 10-minute gradient LC-MS/MS method on the Agilent Ultivo platform achieves baseline separation and sensitive quantitation of 25(OH)D2, 25(OH)D3, and their epimers. Validation metrics demonstrate excellent linearity, precision, and robustness, enabling reliable vitamin D status assessment for research and clinical applications.
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.